P09-07. Balancing reversion of CTL and neutralizing antibody escape mutations within HIV-1 Env upon transmission by Purcell DF, Fernandez C, Alcantara S, Center RJ, Gaeguta A, Campbell S, Peut V, Kent SJ

P17-03. Nanoengineered layer-by-layer capsules as a novel delivery system for HIV vaccines by Kent SJ, Caruso F, Johnston AP, Chong S, Zelikin AN, De Rose R, Whitney PG, Sexton A

P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques by Turner SJ, Doherty PC, Hurt A, Laurie K, Moffat JM, Loh L, Alcantara S, Reece JC, De Rose R, Sexton A, Stambas J, Kent SJ

Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans by Sutton, HJ, Aye, R, Idris, AH, Vistein, R, Nduati, E, Kai, O, Mwacharo, J, Li, X, Gao, X, Andrews, TD, Koutsakos, M, Nguyen, THO, Nekrasov, M, Milburn, P, Eltahla, A, Berry, AA, Kc, N, Chakravarty, S, Sim, BKL, Wheatley, AK, Kent, SJ, Hoffman, SL, Lyke, KE, Bejon, P, Luciani, F, Kedzierska, K, Seder, RA, Ndungu, FM, Cockburn, IA